Amneal Pharmaceuticals Walk-In Interviews for M.Pharm / B.Pharm / Diploma Engineering / D.Pharm / B.Sc / ITI - Multiple Opening in SEZ matoda and Palli

  Amneal Pharmaceuticals Walk-In Interviews for M.Pharm / B.Pharm / Diploma Engineering / D.Pharm / B.Sc / ITI - Multiple Opening Amneal Pha...

 

Amneal Pharmaceuticals Walk-In Interviews for M.Pharm / B.Pharm / Diploma Engineering / D.Pharm / B.Sc / ITI - Multiple Opening

• Amneal Pharmaceuticals Walk-In Interviews for M.Pharm / B.Pharm / Diploma Engineering / D.Pharm / B.Sc / ITI - Multiple Opening in SEZ Matoda and Palli. This is a great opportunity for fresher or experienced people who want to find jobs in the Pharmaceuticals sector. Your dream city for graduate jobs. Job available for everyone who wants to job nearby your places or area. If you want instant notifications of jobs and fresh news about Government jobs or Private sector jobs. So, join our what's App or Telegram groups. Just a small click changes your life it'll helps you to reach your dream job. You can also like or follow our Facebook group.

We, Are looking for competent, dynamic, and motivated candidates for the out plant in Palli,.

Date of interview: 27th Jun 2021(Sunday)

Timing: 9 Am to 1 PM

Interview Location: Amneal Pharmaceuticals Pvt Ltd,

Plot no. 15,16,17 Pharmez,

Village: Motoda, Sarkhej Bavla Road, Ahemdabad 

Sterile manufacturing: 

Job location: SEZ Matoda & Palli

Qualifications: M. Pharm, B.Pharm, Diploma Engineering. D.Phrm, Bsc, ITI

Total Experience: 2 to 7 years 

Working Area; Aseptic and Controlled Area Operation

(Filling, Sealing, Filtration, Intervention Bag printing, Production, QMS, Autoclave, Batch Manufacturing, Terminal sterilization) and Packing ( Track trace, Breveti Machine, Packing Documentation)

Designation: 

• Officer/Executive 30
• Operator /FTE: 30

Interested candidates can send their resumes to neha.modi@amnealindia.com

About Amneal Pharmaceuticals Pvt Ltd

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an incorporated claim to fame drug organization fueled by a powerful U.S. generics business and a developing marked business. Together, our group is attempting to construct quite possibly the most unique drug organizations in our quickly evolving industry. 

The present medical care climate requires another methodology and novel thoughts. While remaining consistent with our standing for quality, administration, and worth, we are rehashing our cycles, our playbook, and our inventive organizations. We are centered around conveying results that meet significant clinical requirements, make quality drugs more available and more reasonable, and give answers for the upcoming wellbeing challenges. 

Our initiative and worldwide partners are profoundly capable and groundbreaking. We have the abilities, scale, and assets for development and achievement. We are deft and decided. We are Amneal and We make sound conceivable 

Products 

Our wide portfolio is the establishment from which we make solidly conceivable. In the US, our generics arrangement of more than 250 medicines* gives patients more reasonable admittance to quality prescriptions. Our developing Specialty Pharma business conveys items that meet significant clinical requirements in focal sensory system problems, parasitic contaminations, and other helpful classifications. We are additionally amped up for our work to bring patients more reasonable biologic treatment choices through our biosimilars program, which today incorporates one recorded item and one close term documenting opportunity.